C2 rs9332739: What Your Genotype Means for Eye Health
The rs9332739 variant is a single nucleotide polymorphism located within the C2 gene. It is widely studied for its statistical association with a reduced risk of developing age-related macular degeneration (AMD).
What each genotype means
Typical risk profile
This is the most common genotype observed in many populations. Research indicates that individuals with this genotype do not carry the specific protective genetic marker associated with this locus, which has been linked to a reduced risk of age-related macular degeneration in some studies. This result should not be interpreted as a diagnosis, as AMD risk is influenced by many other genetic and environmental factors.
This is the major genotype in most populations of European descent.
Potentially reduced risk profile
Carrying one copy of the C allele (also known as the E318D variant) has been associated with a potential protective effect against age-related macular degeneration in some research studies. Because this association is primarily observed in specific populations and can vary by study, this should not be viewed as a guarantee of protection. It is important to remember that many factors contribute to eye health.
This genotype is carried by a minority of individuals in European populations, where the minor allele frequency is typically between 0.04 and 0.08.
Potentially reduced risk profile
Individuals with this genotype carry two copies of the C allele (the E318D variant), which has been linked in several studies to a reduced risk of age-related macular degeneration compared to those without this variant. While evidence suggests this protective association, results can be inconsistent across different ethnicities and study designs. This is a statistical association and not a medical diagnosis of your future eye health.
This genotype is relatively rare in most European-descent populations.
Understanding the rs9332739 Variant
The rs9332739 variant is a specific change in the DNA sequence located on chromosome 6. In the context of human genetics, a single nucleotide polymorphism (SNP) like rs9332739 represents a variation at a single position in the genome. This particular SNP is situated within the C2 gene, which provides instructions for making the complement component 2 protein. This protein is a vital part of the complement system, a group of proteins that work together to help the immune system identify and clear pathogens or damaged cells. Because this variant is located in a region of the genome known to be involved in immune regulation, researchers have focused on how it might influence the body's inflammatory response, particularly in the delicate tissues of the eye.
The Role of the C2 Gene
The C2 gene encodes the complement component 2 protein, which is a key component of the classical pathway of the complement system. The complement system is a complex network of proteins that circulate in the blood and play a critical role in the innate immune response. When activated, these proteins help to destroy foreign invaders and clear away cellular debris. In the eye, the complement system is thought to be involved in maintaining the health of the retina. However, when this system becomes overactive or dysregulated, it can lead to chronic inflammation, which is a hallmark of age-related macular degeneration (AMD). Variations in the C2 gene, such as rs9332739, are believed to influence the activity or expression of this protein, potentially altering the risk profile for retinal diseases.
Research and AMD Associations
Scientific research, including large-scale genome-wide association studies (GWAS), has consistently identified a link between the C2 gene region and age-related macular degeneration. Specifically, the rs9332739 variant has been observed to have a protective effect, meaning individuals carrying the minor allele (the C allele) may show a statistically lower risk of developing advanced AMD compared to those who do not. This association is considered moderate in strength, as AMD is a multifactorial condition influenced by a combination of genetics, environmental factors, and lifestyle choices. It is important to note that while this variant is associated with a decreased risk, it does not guarantee protection, nor does the absence of the variant guarantee the development of the disease. The biological mechanisms underlying this protection are still an active area of investigation.
Population Frequency
The frequency of the rs9332739 variant varies across different ancestral groups. In European populations, the minor allele frequency is typically reported between 0.04 and 0.08. This means that the variant is relatively uncommon but present in a significant portion of the population. Because genetic studies are often conducted in specific cohorts, the exact frequency can differ depending on the ancestry of the group being studied. Understanding these population-specific frequencies is essential for researchers to accurately assess the impact of the variant across diverse global populations. As more genomic data becomes available from non-European ancestries, our understanding of how this variant influences health outcomes globally will continue to evolve.
Interpreting Your Genetic Information
If you have received information about your rs9332739 genotype, it is important to view it as one small piece of a much larger puzzle. Genetic associations are statistical observations made across large groups of people and cannot predict an individual's health outcome with certainty. Many factors, including age, smoking status, diet, and other genetic variants, play a much larger role in the development of eye conditions like AMD. You cannot use this information to diagnose yourself or to predict your future health. If you are concerned about your vision or your risk for eye disease, the most effective step is to schedule a comprehensive eye exam with an ophthalmologist or optometrist. They can provide personalized care based on your clinical history and current eye health, rather than relying on a single genetic marker.
How common is this variant?
The minor allele frequency for rs9332739 is approximately 0.04 to 0.08 in European populations.
Frequently asked questions
Does having the C allele mean I will not get AMD?
No. The rs9332739 variant is associated with a statistically lower risk, but it does not provide complete protection. Many other factors, including age and lifestyle, are significant contributors to AMD risk.
Should I get tested for this variant?
Genetic testing for this specific variant is generally not recommended for clinical decision-making. AMD is a complex disease, and your risk is better assessed through regular eye exams by a professional.
What is the C2 gene?
The C2 gene provides instructions for making a protein that is part of the complement system. This system is a component of the immune system that helps protect the body from infection and inflammation.
Is this variant the only cause of AMD?
No. AMD is a multifactorial condition, meaning it is caused by a combination of many genetic variants and environmental factors. No single gene variant is the sole cause of the disease.
Sources & further reading
Educational information only, last refreshed 9/22/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs9332739?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29